Skip to content

The clinical benefit of topical moisturizers in xerosis patient

The effect ot topical recombinant human epidermal growth factor and moisturizers which contain skin identical lipids on xerosis: a randomized, double blinded controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0001508
Enrollment
80
Registered
2015-05-28
Start date
2013-12-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(moisturizer) : This was a prospective, randomized, double-blind controlled clinical trial. Topical recombinant human EGF-containing cream (Easydew moisturizer) and its vehicle without EGF were

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.All patients were between the ages of 20 and 70 (male or female) 2.All patients had a diagnosis of xerosis as defined by the xerosis severity scale (XSS) presented by Rogers et al and scores of at least 3 on both shins. 3.All of the included patients signed written informed consent for their participation.

Exclusion criteria

Exclusion criteria: Patients were excluded if there was known or suspected sensitivity to test ingredients, current history of any dermatologic diseases requiring treatment (such as psoriasis, atopic dermatitis and eczema), a condition that could interfere with the study’s conduct, use of oral/topical corticosteroids or immunosuppressants, or light therapy within 4 weeks prior to the study.

Design outcomes

Primary

MeasureTime frame
Xerosis Severity scale;Transepidermal water loss;skin hydration status (corneometer)

Secondary

MeasureTime frame
Pruritus grade;Tenderness grade;The Investigator global assessment (IGA) and Subject global assessment (SGA)

Countries

Korea, Republic of

Contacts

Public ContactJoon Ho Shim

Samsung Medical Center

joonho1224@naver.com

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026